GLA and Fabry disease: Advancements in genomic technologies, including whole-exome and whole-genome sequencing, have accelerated the identification of pathogenic variants in lysosomal genes such as GBA (associated with Parkinson’s disease), GALC (Krabbe disease), and GLA (Fabry disease) [92].